Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Cleveland-Cliffs $600 million notes offering
We advised Cleveland-Cliffs on the offering
YXT.COM $25 million IPO
We advised YXT.COM on its IPO and Nasdaq listing
NatWest Group $1.75 billion senior notes offering
We advised NatWest Group on the SEC-registered offering
ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Penumbra $100 million accelerated share repurchase
We advised Penumbra on the ASR transaction
Walgreens Boots Alliance $750 million notes offering
We advised Walgreens Boots Alliance on its debt offering
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
Toyota Motor Credit $2.5 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
Allegro MicroSystems repurchase of 39 million shares held by Sanken Electric
We advised Allegro on the share repurchase, equity offering and incremental and refinancing credit facilities
Morgan Stanley $1 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering